心脏磁共振钆对比剂延迟强化的临床意义及判断预后的预测价值

The Clinical Significance of Cardiac Magnetic Resonance Gadolinium Contrast Agent Delay Enhancement and the Predictive Value of Prognosis

目的:对心脏磁共振钆对比剂延迟强化的临床意义及判断预后的预测价值进行分析。方法:将2018年3月至2019年7月我院扩张型心肌病患者30例作为研究对象,根据心脏磁共振钆对比剂延迟强化情况分为21例实验组与9例对照组,其中实验组患者为有钆对比剂延迟强化,对照组患者为无钆对比剂延迟强化,对比两组患者心脏不良反应发生情况。结果:经过对比后,实验组患者心脏衰竭率、VT/VF发生率及不良事件发生率均优于对照组,两组差异大且有统计学意义(P<0.05)。结论:心脏磁共振钆对比剂延迟强化可对晚期缺血性心脏病与扩张型心肌病进行准确鉴别,同时还可对扩张型心肌病的不良反应情况进行预测,具有较高预后预测价值。

Objective To analyze the clinical significance of cardiac magnetic resonance Gd contrast agent delay enhancement and predictive value of prognosis.Methods Thirty patients with dilated cardiomyopathy in our hospital from March 2018 to July 2019 were divided into 21 experimental groups and 9 control groups according to the delayed enhancement of gadolinium contrast medium in cardiac magnetic resonance.The control group was delayed enhancement without gadolinium contrast medium,and.The adverse cardiac reactions of the two groups were compared.Results After comparison,the incidence of heart failure,VT/VF and adverse events in the experimental group were better than those in the control group,and there was significant difference between the two groups(P<0.05).Conclusion Delayed enhancement of cardiac magnetic resonance Gd contrast agent can accurately identify advanced ischemic heart disease and dilated cardiomyopathy,and can predict the adverse reactions of dilated cardiomyopathy,which has high prognostic value.